Thermo Fisher Scientific Inc. (TMO) Position Increased by Creative Planning

Creative Planning boosted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 12.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,020 shares of the medical research company’s stock after acquiring an additional 2,592 shares during the period. Creative Planning’s holdings in Thermo Fisher Scientific were worth $4,371,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of TMO. Vanguard Group Inc. raised its holdings in shares of Thermo Fisher Scientific by 2.4% during the second quarter. Vanguard Group Inc. now owns 26,600,394 shares of the medical research company’s stock worth $4,640,970,000 after purchasing an additional 629,093 shares during the period. BlackRock Inc. raised its holdings in shares of Thermo Fisher Scientific by 1.6% during the second quarter. BlackRock Inc. now owns 23,355,469 shares of the medical research company’s stock worth $4,074,828,000 after purchasing an additional 366,584 shares during the period. Capital Research Global Investors raised its holdings in shares of Thermo Fisher Scientific by 29.8% during the second quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock worth $3,019,185,000 after purchasing an additional 3,973,136 shares during the period. Capital World Investors raised its holdings in shares of Thermo Fisher Scientific by 6.1% during the second quarter. Capital World Investors now owns 11,759,734 shares of the medical research company’s stock worth $2,051,721,000 after purchasing an additional 671,637 shares during the period. Finally, Longview Partners Guernsey LTD raised its holdings in shares of Thermo Fisher Scientific by 7.4% during the third quarter. Longview Partners Guernsey LTD now owns 4,564,913 shares of the medical research company’s stock worth $863,682,000 after purchasing an additional 313,782 shares during the period. 86.25% of the stock is currently owned by hedge funds and other institutional investors.

A number of analysts have weighed in on TMO shares. Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Monday, October 30th. Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. Leerink Swann increased their target price on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a report on Monday, October 9th. Goldman Sachs Group started coverage on shares of Thermo Fisher Scientific in a report on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price on the stock. Finally, BTIG Research started coverage on shares of Thermo Fisher Scientific in a report on Friday, January 5th. They set a “buy” rating and a $230.00 target price on the stock. Two analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $212.21.

Thermo Fisher Scientific Inc. (NYSE TMO) opened at $213.51 on Friday. The company has a market cap of $85,175.43, a PE ratio of 36.25, a PEG ratio of 1.73 and a beta of 1.06. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc. has a 12-month low of $140.00 and a 12-month high of $214.57.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping the consensus estimate of $2.24 by $0.07. The business had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company’s quarterly revenue was up 13.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.03 earnings per share. research analysts expect that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Monday, January 15th. Stockholders of record on Friday, December 15th were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, December 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

In other news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the transaction, the chief executive officer now owns 302,577 shares in the company, valued at $58,016,113.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.49% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This news story was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://ledgergazette.com/2018/01/21/thermo-fisher-scientific-inc-tmo-position-increased-by-creative-planning.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply